Fosravuconazole L-Lysine Ethanolate | Interleukin Related interleukin-related.com

Product Name :
Fosravuconazole L-Lysine Ethanolate

Search keywords :
L-Lysine

drugId :
null

Target Vo:
Cytochrome P450 51

Target Vo Short Name :
CYP51

Moa_Name:
Cytochrome P450 51 inhibitors

First Approval Country :
Japan

First Approval Date Filter:
2018

Origin Company_Name :
Eisai Co Ltd

Active Company_Name :
Sato Pharmaceutical Ltd

Active Indication_Name:
Onychomycosis

In Active Indication_Name:
Chagas Disease

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Tafolecimab References
SREBP1 Rabbit pAb Description
MMP1 Antibody: MMP1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 54 kDa, targeting to MMP1. It can be used for WB,IP assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts